Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Main Authors: Wong, Karen K., Davey, Richard T., Hewlett, Angela L., Kraft, Colleen S., Mehta, Aneesh K., Mulligan, Mark J., Beck, Allison, Dorman, William, Kratochvil, Christopher J., Lai, Lilin, Palmore, Tara N., Rogers, Susan, Smith, Philip W., Suffredini, Anthony F., Wolcott, Mark, Ströher, Ute, Uyeki, Timothy M.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2016
Assuntos:
Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946014/
https://ncbi.nlm.nih.gov/pubmed/27118786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw256
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares